IL109044A - Pneumococcal surface protein "A" fragment and vaccine containing it - Google Patents

Pneumococcal surface protein "A" fragment and vaccine containing it

Info

Publication number
IL109044A
IL109044A IL10904494A IL10904494A IL109044A IL 109044 A IL109044 A IL 109044A IL 10904494 A IL10904494 A IL 10904494A IL 10904494 A IL10904494 A IL 10904494A IL 109044 A IL109044 A IL 109044A
Authority
IL
Israel
Prior art keywords
fragment
surface protein
vaccine containing
pneumococcal surface
pneumococcal
Prior art date
Application number
IL10904494A
Other languages
English (en)
Other versions
IL109044A0 (en
Inventor
David E Briles
Janet L Yother
Larry S Mcdaniel
Original Assignee
Uab Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uab Research Foundation filed Critical Uab Research Foundation
Publication of IL109044A0 publication Critical patent/IL109044A0/xx
Publication of IL109044A publication Critical patent/IL109044A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Analytical Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL10904494A 1993-04-20 1994-03-20 Pneumococcal surface protein "A" fragment and vaccine containing it IL109044A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4889693A 1993-04-20 1993-04-20

Publications (2)

Publication Number Publication Date
IL109044A0 IL109044A0 (en) 1994-06-24
IL109044A true IL109044A (en) 2000-08-31

Family

ID=21957026

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10904494A IL109044A (en) 1993-04-20 1994-03-20 Pneumococcal surface protein "A" fragment and vaccine containing it

Country Status (8)

Country Link
EP (1) EP0622081A3 (fr)
JP (2) JP3245298B2 (fr)
AU (1) AU682018B2 (fr)
CA (1) CA2116261A1 (fr)
FI (1) FI941695A (fr)
IL (1) IL109044A (fr)
NO (1) NO941420L (fr)
ZA (1) ZA941584B (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6027734A (en) * 1991-02-15 2000-02-22 Uab Research Foundation Mucosal administration of pneumococcal antigens
US5980909A (en) * 1991-02-15 1999-11-09 Uab Research Foundation Epitopic regions of pneumococcal surface protein A
US6592876B1 (en) * 1993-04-20 2003-07-15 Uab Research Foundation Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products
US5955089A (en) * 1993-04-20 1999-09-21 Uab Research Foundation Strain selection of pneumococcal surface proteins
AU734488B2 (en) * 1994-05-20 2001-06-14 Uab Research Foundation Mucosal administration of pneumococcal antigens
ZA964896B (en) * 1995-06-07 1997-01-08 Connaught Lab Expression of lipoproteins
US7078042B2 (en) 1995-09-15 2006-07-18 Uab Research Foundation Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor
DE69735715T2 (de) * 1996-05-01 2007-03-29 The Rockefeller University Cholin-bindendes Protein, welches als gegen Pneumokokken gerichtetes Vakzin verwendet wird
US6245335B1 (en) 1996-05-01 2001-06-12 The Rockefeller University Choline binding proteins for anti-pneumococcal vaccines
DE69737125T3 (de) 1996-10-31 2015-02-26 Human Genome Sciences, Inc. Streptococcus pneumoniae-Antigene und Impfstoffe
AU5355398A (en) * 1996-11-12 1998-06-03 Regents Of The University Of Minnesota C3 binding protein of (streptococcus pneumoniae)
US6676943B1 (en) 1997-04-24 2004-01-13 Regents Of The University Of Minnesota Human complement C3-degrading protein from Streptococcus pneumoniae
CA2328399A1 (fr) * 1998-04-23 1999-10-28 University Of Alabama At Birmingham Proteine de surface pneumococcique c(pspc), regions epitopes et selection de souches d'une telle proteine, et utilisations correspondantes
EP2053126A1 (fr) * 1998-07-27 2009-04-29 Sanofi Pasteur Limited Protéines de pneumonie à streptocoques et molécules d'acide nucléique
US6936252B2 (en) 1998-07-27 2005-08-30 Microbial Technics Limited Streptococcus pneumoniae proteins and nucleic acid molecules
US6869767B1 (en) 1999-06-11 2005-03-22 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Detection of Streptococcus pneumoniae and immunization against Streptococcus pneumoniae infection
AU4683299A (en) * 1999-06-11 2001-01-02 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Detection of streptococcus pneumoniae and immunization against streptococcus pneumoniae infection
EP1967591A3 (fr) * 2000-03-16 2008-12-03 The Children's Hospital Of Philadelphia Méthode pour déterminer l'utilité d'un composé de test pour atténuer une infection pneumococcique dans un animal
US9815886B2 (en) 2014-10-28 2017-11-14 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
WO2017170494A1 (fr) * 2016-03-29 2017-10-05 国立大学法人東京大学 Vaccin contre l'obésité
KR102608642B1 (ko) 2016-12-03 2023-11-30 더 유에이비 리서치 파운데이션 폐렴구균 표면 단백질 a의 선택된 알파 나선 도메인 및 프롤린 풍부 도메인을 조합한 폐렴구균 백신
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE168132T1 (de) * 1991-02-15 1998-07-15 Uab Research Foundation Strukturgen von pneumokokken-protein

Also Published As

Publication number Publication date
EP0622081A3 (en) 1995-11-15
FI941695A0 (fi) 1994-04-13
EP0622081A2 (fr) 1994-11-02
FI941695A (fi) 1994-10-21
JP2002167399A (ja) 2002-06-11
JP3245298B2 (ja) 2002-01-07
JPH07126291A (ja) 1995-05-16
NO941420D0 (no) 1994-04-19
IL109044A0 (en) 1994-06-24
ZA941584B (en) 1994-10-12
AU5769694A (en) 1994-10-27
AU682018B2 (en) 1997-09-18
CA2116261A1 (fr) 1994-10-21
NO941420L (no) 1994-10-21

Similar Documents

Publication Publication Date Title
IL109044A (en) Pneumococcal surface protein "A" fragment and vaccine containing it
CZ197595A3 (en) Vaccine preparations
IL113775A0 (en) Epitopic regions of pneumococcal surface protein A
EP0445801A3 (en) Peptide and its use
GR3031296T3 (en) Cyclic peptides and use thereof
GB9325496D0 (en) Vaccines
GB9516293D0 (en) Novel peptides and their use as vaccines
GB2282601B (en) Antigenically-active proteins/polypeptides and coronavirus vaccines containing the same
IL90833A0 (en) Immunogenic peptide
ZA948685B (en) Vaccines
ZA948729B (en) Vaccines
ZA948450B (en) Bedding and related material
DE69405544D1 (en) 4'-0-sulfonylanthracyclinderivate
ZA954030B (en) Epitopic regions of pneumococcal surface protein A
ZA944483B (en) Peptides for use in medicine
GB9106568D0 (en) Recombinant antigen
HU9800434D0 (en) 2-chloro-3-cyano-benzaldehyde and process for it's preparation
IL116541A0 (en) Helicobacter proteins and vaccines
SG69983A1 (en) Novel peptides the preparation and use thereof
GB2284418B (en) Z-Benzylidene-Tetrahydroquinolines and analogues thereof
ZA955499B (en) Helicobacter proteins and vaccines
ZA959106B (en) Alzheimer's peptide
IE891651L (en) Amphiphilic peptides and use thereof
ZA949128B (en) Vaccine
GB9323754D0 (en) Vaccine

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed